Targeting the Cav1.2-KCa1.1 axis prevents rabies virus internalization and protects against lethal infection
PLOS Pathogens · 2026
DOI: 10.1371/journal.ppat.1014675 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2026. Verfasst von Ziruo Sun und 18 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin…. Hauptthemen laut MEDLINE: Calcium Channels, L-Type, Rabies virus, Rabies, Virus Internalization. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Innovation Program of Chinese Academy of Agricultural Sciences.
Abstract (Originalsprache)
Rabies is an almost always fatal disease caused by rabies virus (RABV). Once RABV enters the central nervous system, the mortality rate is almost 100%. Therefore, preventing RABV from entering the nervous system is crucial for the development of anti-RABV therapeutics. Here, we found that the L-type calcium channel Cav1.2 pore-forming subunit (Ca v 1.2) and potassium calcium-activated channel subfamily M alpha 1 (KCa1.1) are involved in the internalization of RABV using an siRNA approach. RABV glycoprotein interacts with Ca v 1.2, a process that is required for the subsequent activation of the channel. The activated Ca v 1.2 then interacts with and activates KCa1.1 to regulate the endocytosis of RABV by promoting the F-actin polymerization. Importantly, diltiazem, a blocker of Ca v 1.2 and an FDA-approved drug, has been shown to substantially reduce mortality in mice infected with RABV. Approximately 70% of mice survived following treatment with diltiazem at 50 mg/kg, whereas the 25 mg/kg dose resulted in 26% survival. Our findings suggest that Ca v 1.2 is a promising target for the development of antiviral drugs against rabies and enhances our comprehension of the RABV entry mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, People's Republic of China.
- National High Containment Laboratory for Animal Disease Control and Prevention, Harbin, People's Republic of China.
- Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, People's Republic of China.
ORCID-Profile: Jinliang Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Innovation Program of Chinese Academy of Agricultural Sciences
Zitieren
APA
Sun, Z., Wang, J., Wen, Z., Shuai, L., Sun, W., Yang, M., Wang, J., Chen, J., Mi, T., Zhou, X., Zhou, P., Lv, N., Zhao, Z., Ge, J., Chen, W., Wang, X., Wang, C., Bu, Z., & Wang, J. (2026). Targeting the Cav1.2-KCa1.1 axis prevents rabies virus internalization and protects against lethal infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1014675
Vancouver
Sun Z, Wang J, Wen Z, Shuai L, Sun W, Yang M, et al. Targeting the Cav1.2-KCa1.1 axis prevents rabies virus internalization and protects against lethal infection. PLOS Pathogens. 2026. doi:10.1371/journal.ppat.1014675
BibTeX
@article{Sun2026,
author = {Sun, Ziruo and Wang, Jinqiu and Wen, Zhiyuan and Shuai, Lei and Sun, Wenjing and Yang, Mengjie and Wang, Jinyu and Chen, Junyu and Mi, Tengteng and Zhou, Xianjing and Zhou, Peiran and Lv, Nannan and Zhao, Zhenbo and Ge, Jinying and Chen, Weiye and Wang, Xijun and Wang, Chong and Bu, Zhigao and Wang, Jinliang},
title = {Targeting the Cav1.2-KCa1.1 axis prevents rabies virus internalization and protects against lethal infection},
journal = {PLOS Pathogens},
year = {2026},
doi = {10.1371/journal.ppat.1014675}
}
EUVIMED